Earth observations from DSCOVR EPIC instrument

The National Oceanic and Atmospheric Administration (NOAA) Deep Space Climate Observatory (DSCOVR) spacecraft was launched on 11 February 2015 and in June 2015 achieved its orbit at the first Lagrange point (L1), 1.5 million km from Earth toward the sun. There are two National Aeronautics and Space Administration (NASA) Earth-observing instruments on board: the Earth Polychromatic Imaging Camera (EPIC) and the National Institute of Standards and Technology Advanced Radiometer (NISTAR). The purpose of this paper is to describe various capabilities of the DSCOVR EPIC instrument. EPIC views the entire sunlit Earth from sunrise to sunset at the backscattering direction (scattering angles between 168.5° and 175.5°) with 10 narrowband filters: 317, 325, 340, 388, 443, 552, 680, 688, 764, and 779 nm. We discuss a number of preprocessing steps necessary for EPIC calibration including the geolocation algorithm and the radiometric calibration for each wavelength channel in terms of EPIC counts per second for conversion to reflectance units. The principal EPIC products are total ozone (O3) amount, scene reflectivity, erythemal irradiance, ultraviolet (UV) aerosol properties, sulfur dioxide (SO2) for volcanic eruptions, surface spectral reflectance, vegetation properties, and cloud products including cloud height. Finally, we describe the observation of horizontally oriented ice crystals in clouds and the unexpected use of the O2 B-band absorption for vegetation properties.The NASA GSFC DSCOVR project is funded by NASA Earth Science Division. We gratefully acknowledge the work by S. Taylor and B. Fisher for help with the SO2 retrievals and Marshall Sutton, Carl Hostetter, and the EPIC NISTAR project for help with EPIC data. We also would like to thank the EPIC Cloud Algorithm team, especially Dr. Gala Wind, for the contribution to the EPIC cloud products. (NASA Earth Science Division)Accepted manuscrip

Illness perception and related behaviour in lower respiratory tract infections—a European study

Background. Lower respiratory tract infection (LRTI) is a common presentation in primary care, but little is known about associated patients’ illness perception and related behaviour. Objective. To describe illness perceptions and related behaviour in patients with LRTI visiting their general practitioner (GP) and identify differences between European regions and types of health care system. Methods. Adult patients presenting with acute cough were included. GPs recorded co morbidities and clinical findings. Patients filled out a diary for up to 4 weeks on their symptoms, illness perception and related behaviour. The chi-square test was used to compare proportions between groups and the Mann-Whitney U or Kruskal Wallis tests were used to compare means. Results. Three thousand one hundred six patients from 12 European countries were included. Eighty-one per cent (n = 2530) of the patients completed the diary. Patients were feeling unwell for a mean of 9 (SD 8) days prior to consulting. More than half experienced impairment of normal or social activities for at least 1 week and were absent from work/school for a mean of 4 (SD 5) days. On average patients felt recovered 2 weeks after visiting their GP, but 21% (n = 539) of the patients did not feel recovered after 4 weeks. Twenty-seven per cent (n = 691) reported feeling anxious or depressed, and 28% (n = 702) re-consulted their GP at some point during the illness episode. Reported illness duration and days absent from work/school differed between countries and regions (North-West versus South-East), but there was little difference in reported illness course and related behaviour between health care systems (direct access versus gate-keeping). Conclusion. Illness course, perception and related behaviour in LRTI differ considerably between countries. These finding should be taken into account when developing International guidelines for LRTI and interventions for setting realistic expectations about illness course

Cow-calf enterprises on wheat farms in the Columbia Basin of Oregon

Published November 1967. Facts and recommendations in this publication may no longer be valid. Please look for up-to-date information in the OSU Extension Catalog: http://extension.oregonstate.edu/catalo

The Development of Peptide-Based Tools for the Analysis of Angiogenesis

SummaryLimitations to the application of molecularly targeted cancer therapies are the inability to accurately match patient with effective treatment and the absence of a prompt readout of posttreatment response. Noninvasive agents that rapidly report vascular endothelial growth factor (VEGF) levels using positron emission tomography (PET) have the potential to enhance anti-angiogenesis therapies. Using phage display, two distinct classes of peptides were identified that bind to VEGF with nanomolar affinity and high selectivity. Co-crystal structures of these different peptide classes demonstrate that both bind to the receptor-binding region of VEGF. 18F-radiolabelling of these peptides facilitated the acquisition of PET images of tumor VEGF levels in a HM7 xenograph model. The images obtained from one 59-residue probe, 18F-Z-3B, 2 hr postinjection are comparable to those obtained with anti-VEGF antibody B20 72 hr postinjection. Furthermore, VEGF levels in growing SKOV3 tumors were followed using 18F-Z-3B as a PET probe with VEGF levels increasing with tumor size

The Living Planet Index (LPI) for migratory freshwater fish:Technical Report

Migratory freshwater fish (i.e. fish that use freshwater systems, either partly or exclusively) occur around the world and travel between critical habitats to complete their life cycle. They are disproportionately threatened compared to other fish groups but global trends in abun-dance, regional differences and drivers of patterns have not yet been comprehensively described. Using abundance information from the Living Planet Database, we found widespread declines between 1970 and 2016 in tropical and temperate areas and across all regions, all migration categories and all populations. Globally, migratory freshwater fish have declined by an average of 76%. Average declines have been more pronounced in Europe (-93%) and Latin America & Caribbean (-84%), and least in North America (-28%). The percentage of species represented was highest in the two temperate regions of Europe and North America (almost 50%). For the continents of Africa, Asia, Oceania, and South America, data was highly deficient, and we advise against making conclusions on the status of migratory freshwater SUMMARYfish in these areas. Potamodromous fish, have declined more than fish migrating between fresh and salt water on average (-83% vs -73%). Populations that are known to be affected by threats anywhere along their migration routes show an average decline of 94% while those not threatened at the population level have increased on av-erage. Habitat degradation, alteration, and loss accounted for around a half of threats to migratory fish, while over-exploitation accounted for around one-third. Protected, regulated and exploited populations decreased less than unmanaged ones, with the most often recorded actions being related to fisheries regulations, including fishing restrictions, no-take zones, fisheries closures, bycatch reductions and stocking (these were most com-mon in North America and Europe). Recorded reasons for observed increases tended to be mostly unknown or un-described, especially in tropical regions. This information is needed to assemble a more complete picture to assess how declines in migratory freshwater fishes could be reduced or reversed. Our findings confirm that migratory freshwater fish may be more threatened throughout their range than previously documented

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Hypermethylation of the DLC1 CpG island does not alter gene expression in canine lymphoma

<p>Abstract</p> <p>Background</p> <p>This study is a comparative epigenetic evaluation of the methylation status of the <it>DLC1 </it>tumor suppressor gene in naturally-occurring canine lymphoma. Canine non-Hodgkin's lymphoma (NHL) has been proposed to be a relevant preclinical model that occurs spontaneously and may share causative factors with human NHL due to a shared home environment. The canine <it>DLC1 </it>mRNA sequence was derived from normal tissue. Using lymphoid samples from 21 dogs with NHL and 7 normal dogs, the methylation status of the promoter CpG island of the gene was defined for each sample using combined bisulfite restriction analysis (COBRA), methylation-specific PCR (MSP), and bisulfite sequencing methods. Relative gene expression was determined using real-time PCR.</p> <p>Results</p> <p>The mRNA sequence of canine <it>DLC1 </it>is highly similar to the human orthologue and contains all protein functional groups, with 97% or greater similarity in functional regions. Hypermethylation of the 5' and 3' flanking regions of the promoter was statistically significantly associated with the NHL phenotype, but was not associated with silencing of expression or differences in survival.</p> <p>Conclusion</p> <p>The canine <it>DLC1 </it>is constructed highly similarly to the human gene, which has been shown to be an important tumor suppressor in many forms of cancer. As in human NHL, the promoter CpG island of <it>DLC1 </it>in canine NHL samples is abnormally hypermethylated, relative to normal lymphoid tissue. This study confirms that hypermethylation occurs in canine cancers, further supporting the use of companion dogs as comparative models of disease for evaluation of carcinogenesis, biomarker diagnosis, and therapy.</p